Raymond James & Associates’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.34M | Sell |
47,257
-3,112
| -6% | -$220K | ﹤0.01% | 1903 |
|
|
2024
Q2 | $3.34M | Sell |
50,369
-2,969
| -6% | -$197K | ﹤0.01% | 1852 |
|
|
2024
Q1 | $3.62M | Sell |
53,338
-78,605
| -60% | -$5.34M | ﹤0.01% | 1796 |
|
|
2023
Q4 | $8.15M | Sell |
131,943
-38,979
| -23% | -$2.41M | 0.01% | 1229 |
|
|
2023
Q3 | $10.1M | Sell |
170,922
-630
| -0.4% | -$37.2K | 0.01% | 1025 |
|
|
2023
Q2 | $10.2M | Sell |
171,552
-19,752
| -10% | -$1.18M | 0.01% | 1035 |
|
|
2023
Q1 | $11.2M | Buy |
191,304
+73,008
| +62% | +$4.27M | 0.01% | 966 |
|
|
2022
Q4 | $7.34M | Buy |
118,296
+735
| +0.6% | +$45.6K | 0.01% | 1180 |
|
|
2022
Q3 | $6.64M | Buy |
117,561
+20,010
| +21% | +$1.13M | 0.01% | 1187 |
|
|
2022
Q2 | $6.23M | Buy |
97,551
+6,690
| +7% | +$427K | 0.01% | 1255 |
|
|
2022
Q1 | $5.88M | Sell |
90,861
-3,477
| -4% | -$225K | 0.01% | 1393 |
|
|
2021
Q4 | $6.28M | Buy |
94,338
+4,062
| +4% | +$270K | 0.01% | 1397 |
|
|
2021
Q3 | $5.51M | Buy |
90,276
+2,736
| +3% | +$167K | 0.01% | 1435 |
|
|
2021
Q2 | $5.42M | Buy |
87,540
+5,691
| +7% | +$352K | ﹤0.01% | 1440 |
|
|
2021
Q1 | $4.85M | Buy |
81,849
+7,587
| +10% | +$449K | ﹤0.01% | 1446 |
|
|
2020
Q4 | $4.44M | Buy |
74,262
+11,601
| +19% | +$694K | ﹤0.01% | 1404 |
|
|
2020
Q3 | $3.42M | Sell |
62,661
-17,430
| -22% | -$950K | ﹤0.01% | 1427 |
|
|
2020
Q2 | $4.11M | Buy |
80,091
+17,589
| +28% | +$902K | 0.01% | 1309 |
|
|
2020
Q1 | $2.8M | Buy |
62,502
+52,290
| +512% | +$2.35M | ﹤0.01% | 1385 |
|
|
2019
Q4 | $545K | Sell |
10,212
-23,469
| -70% | -$1.25M | ﹤0.01% | 2650 |
|
|
2019
Q3 | $1.57M | Sell |
33,681
-8,277
| -20% | -$386K | ﹤0.01% | 1912 |
|
|
2019
Q2 | $2.11M | Buy |
41,958
+1,260
| +3% | +$63.3K | ﹤0.01% | 1767 |
|
|
2019
Q1 | $2.09M | Buy |
40,698
+711
| +2% | +$36.5K | ﹤0.01% | 1741 |
|
|
2018
Q4 | $1.88M | Sell |
39,987
-16,464
| -29% | -$772K | ﹤0.01% | 1699 |
|
|
2018
Q3 | $3.16M | Sell |
56,451
-3,330
| -6% | -$186K | ﹤0.01% | 1519 |
|
|
2018
Q2 | $3.02M | Sell |
59,781
-13,104
| -18% | -$661K | 0.01% | 1499 |
|
|
2018
Q1 | $3.58M | Buy |
72,885
+8,166
| +13% | +$402K | 0.01% | 1336 |
|
|
2017
Q4 | $3.33M | Buy |
64,719
+4,128
| +7% | +$212K | 0.01% | 1365 |
|
|
2017
Q3 | $3.16M | Sell |
60,591
-4,425
| -7% | -$231K | 0.01% | 1330 |
|
|
2017
Q2 | $3.36M | Buy |
65,016
+2,397
| +4% | +$124K | 0.01% | 1243 |
|
|
2017
Q1 | $3.15M | Buy |
62,619
+11,136
| +22% | +$560K | 0.01% | 1258 |
|
|
2016
Q4 | $2.43M | Buy |
51,483
+4,089
| +9% | +$193K | 0.01% | 1372 |
|
|
2016
Q3 | $2.36M | Sell |
47,394
-2,979
| -6% | -$148K | 0.01% | 1358 |
|
|
2016
Q2 | $2.43M | Sell |
50,373
-3,192
| -6% | -$154K | 0.01% | 1225 |
|
|
2016
Q1 | $2.45M | Sell |
53,565
-36,588
| -41% | -$1.67M | 0.01% | 1171 |
|
|
2015
Q4 | $4.86M | Buy |
90,153
+2,874
| +3% | +$155K | 0.02% | 819 |
|
|
2015
Q3 | $4.31M | Sell |
87,279
-146,592
| -63% | -$7.23M | 0.02% | 820 |
|
|
2015
Q2 | $13.6M | Buy |
233,871
+102,222
| +78% | +$5.96M | 0.05% | 414 |
|
|
2015
Q1 | $7.57M | Buy |
131,649
+27,018
| +26% | +$1.55M | 0.03% | 561 |
|
|
2014
Q4 | $5.28M | Sell |
104,631
-56,559
| -35% | -$2.85M | 0.03% | 656 |
|
|
2014
Q3 | $7.54M | Buy |
161,190
+23,820
| +17% | +$1.11M | 0.04% | 450 |
|
|
2014
Q2 | $6.19M | Buy |
137,370
+31,011
| +29% | +$1.4M | 0.04% | 538 |
|
|
2014
Q1 | $4.49M | Buy |
106,359
+14,793
| +16% | +$625K | 0.03% | 622 |
|
|
2013
Q4 | $3.6M | Buy |
91,566
+8,505
| +10% | +$335K | 0.03% | 663 |
|
|
2013
Q3 | $2.95M | Sell |
83,061
-8,055
| -9% | -$286K | 0.03% | 693 |
|
|
2013
Q2 | $3.03M | Buy |
+91,116
| New | +$3.03M | 0.03% | 620 |
|